Compare ANDE & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANDE | ENOV |
|---|---|---|
| Founded | 1947 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Fluid Controls |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | N/A | 2008 |
| Metric | ANDE | ENOV |
|---|---|---|
| Price | $53.97 | $26.50 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $58.33 | $51.17 |
| AVG Volume (30 Days) | 311.3K | ★ 839.8K |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.13 | N/A |
| Revenue | ★ $11,595,817,000.00 | $2,233,266,000.00 |
| Revenue This Year | $6.47 | $9.27 |
| Revenue Next Year | $3.36 | $4.56 |
| P/E Ratio | $25.34 | ★ N/A |
| Revenue Growth | 2.19 | ★ 11.57 |
| 52 Week Low | $31.03 | $25.47 |
| 52 Week High | $54.38 | $49.38 |
| Indicator | ANDE | ENOV |
|---|---|---|
| Relative Strength Index (RSI) | 67.53 | 36.46 |
| Support Level | $49.14 | $26.49 |
| Resistance Level | $53.32 | $28.27 |
| Average True Range (ATR) | 1.43 | 1.15 |
| MACD | 0.02 | -0.15 |
| Stochastic Oscillator | 93.32 | 6.43 |
Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.